- Home
- TRST vs TRVI Comparison
TRST vs TRVI Comparison
Compare TRST & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- TRVI
- Stock Information
- Founded
- TRST 1902
- TRVI 2011
- Country
- TRST United States
- TRVI United States
- Employees
- TRST N/A
- TRVI N/A
- Industry
- TRST Major Banks
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- TRVI Health Care
- Exchange
- TRST Nasdaq
- TRVI Nasdaq
- Market Cap
- TRST 669.9M
- TRVI 725.7M
- IPO Year
- TRST N/A
- TRVI 2019
- Fundamental
- Price
- TRST $33.35
- TRVI $7.42
- Analyst Decision
- TRST
- TRVI Strong Buy
- Analyst Count
- TRST 0
- TRVI 9
- Target Price
- TRST N/A
- TRVI $19.50
- AVG Volume (30 Days)
- TRST 83.0K
- TRVI 1.8M
- Earning Date
- TRST 07-21-2025
- TRVI 08-07-2025
- Dividend Yield
- TRST 4.34%
- TRVI N/A
- EPS Growth
- TRST 8.63
- TRVI N/A
- EPS
- TRST 2.81
- TRVI N/A
- Revenue
- TRST $177,008,000.00
- TRVI N/A
- Revenue This Year
- TRST $13.13
- TRVI N/A
- Revenue Next Year
- TRST N/A
- TRVI N/A
- P/E Ratio
- TRST $11.71
- TRVI N/A
- Revenue Growth
- TRST 2.80
- TRVI N/A
- 52 Week Low
- TRST $27.18
- TRVI $2.36
- 52 Week High
- TRST $38.89
- TRVI $8.11
- Technical
- Relative Strength Index (RSI)
- TRST 44.49
- TRVI 59.47
- Support Level
- TRST $32.82
- TRVI $7.08
- Resistance Level
- TRST $33.34
- TRVI $7.74
- Average True Range (ATR)
- TRST 0.69
- TRVI 0.42
- MACD
- TRST -0.27
- TRVI -0.05
- Stochastic Oscillator
- TRST 18.86
- TRVI 55.77
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.